Lowe’s, Target, GlaxoSmithKline and others

Check out the companies making headlines before the bell: Lowe’s (LOW) – Lowe’s rose 2.5% in the premarket after beating

Read more

Sanofi, GlaxoSmithKline set to start Phase 3 trials for COVID-19 vaccine after earlier setback

A COVID-19 vaccine developed by Sanofi and GlaxoSmithKline showed a robust immune response in early-stage clinical trial results, enabling them

Read more

Pin It on Pinterest